Related Experiment Video
Updated: Jun 26, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
Accelerated partial breast irradiation trials: diversity in rationale and design
Mariella Mannino1, John Yarnold
1Academic Radiotherapy Department, The Institute of Cancer Research, Sutton, UK.
Accelerated partial breast irradiation is being tested against whole breast radiotherapy in seven trials. These studies will provide crucial evidence on the effectiveness of accelerated partial breast irradiation for breast cancer patients.
Area of Science:
- Radiation Oncology
- Surgical Oncology
- Clinical Trials
Background:
- Breast conservation surgery is often followed by radiotherapy.
- Accelerated partial breast irradiation (APBI) is an alternative to whole breast radiotherapy (WBRT).
- Current trials investigate various APBI techniques and dose schedules.
Purpose of the Study:
- To compare accelerated partial breast irradiation (APBI) with whole breast radiotherapy (WBRT).
- To evaluate the efficacy and safety of APBI based on different target volume concepts.
- To generate level I evidence for APBI in breast cancer treatment.
Main Methods:
- Seven ongoing randomized controlled trials.
- Comparison of APBI techniques (brachytherapy, teletherapy) versus WBRT.
- Focus on clinical and planning target volumes based on relapse patterns.
Main Results:
- Ongoing trials will provide level I evidence.
- Relapse patterns are not fully defined in existing literature.
- WBRT may reduce relapse in other breast quadrants.
Conclusions:
- Level I evidence is pending from ongoing trials.
- The biological model of relapse influences APBI target volume definitions.
- Long-term patient follow-up is essential for definitive results.
Related Concept Videos
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Randomized Experiments
Simple randomization
Simple...
